LFWD icon

ReWalk Robotics

1.41 USD
-0.06
4.08%
At close Apr 30, 4:00 PM EDT
After hours
1.40
-0.01
0.71%
1 day
-4.08%
5 days
-9.03%
1 month
-17.06%
3 months
-0.70%
6 months
-38.96%
Year to date
-36.77%
1 year
-70.32%
5 years
-82.17%
10 years
-99.93%
 

About: Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings are the ReWalk Exoskeleton, the ReStore Exo-Suit, the MyoCycle FES bikes, and AlterG Anti-Gravity systems. It operates through markets in the United States, Israel, and Germany.

Employees: 80

0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

195% more call options, than puts

Call options by funds: $56K | Put options by funds: $19K

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

10% more funds holding

Funds holding: 21 [Q3] → 23 (+2) [Q4]

4.07% less ownership

Funds ownership: 7.08% [Q3] → 3.0% (-4.07%) [Q4]

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

77% less capital invested

Capital invested by funds: $2.02M [Q3] → $458K (-$1.56M) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4
184%
upside
Avg. target
$9
538%
upside
High target
$13
822%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Lake Street
Ben Haynor
44% 1-year accuracy
4 / 9 met price target
184%upside
$4
Buy
Maintained
11 Mar 2025
HC Wainwright & Co.
Swayampakula Ramakanth
30% 1-year accuracy
57 / 192 met price target
822%upside
$13
Buy
Reiterated
11 Mar 2025
Laidlaw & Co.
Yale Jen
33% 1-year accuracy
2 / 6 met price target
609%upside
$10
Buy
Initiated
10 Feb 2025

Financial journalist opinion

Based on 4 articles about LFWD published over the past 30 days

Neutral
GlobeNewsWire
1 day ago
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Approval signals important progress in U.S. market expansion as major commercial health insurers begin to follow precedent set with Medicare reimbursement for personal exoskeletons established in 2024 Decision to cover device arrives shortly after the launch of the ReWalk 7 Personal Exoskeleton, which was released for sales in the U.S. earlier this month MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 29, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton
Neutral
GlobeNewsWire
6 days ago
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton
Positive
Zacks Investment Research
2 weeks ago
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
Lifeward launches ReWalk 7 in the United States, offering advanced mobility, greater control and smarter walking for individuals with spinal cord injuries.
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7
Neutral
GlobeNewsWire
2 weeks ago
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
Neutral
Zacks Investment Research
1 month ago
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton
LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton
Neutral
GlobeNewsWire
1 month ago
FDA Issues Clearance for ReWalk 7 Exoskeleton
Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury Seventh Generation of Industry-Leading Exoskeleton Includes New and Enhanced Features for Individuals with Spinal Cord Injury
FDA Issues Clearance for ReWalk 7 Exoskeleton
Neutral
Seeking Alpha
1 month ago
Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript
Lifeward Ltd. (NASDAQ:LFWD ) Q4 2024 Earnings Conference Call March 7, 2025 8:30 AM ET Company Participants Mike Lawless - CFO Larry Jasinski - CEO Almog Adar - VP, Finance Conference Call Participants Yale Jen - Laidlaw & Company Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C.
Lifeward Ltd. (LFWD) Q4 2024 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates
Lifeward (LFWD) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.35 per share a year ago.
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Record quarterly and annual revenue of $7.5M and $25.7M, respectively Continued strong growth in U.S. pipeline of ReWalk opportunities with over 110 qualified leads in process Strategic s hift t owards p rofitability: 2025 Sustainable Growth Plan f ocuses on growth of c ore p roduct l ines with a s treamlined c ost s tructure and r educed o perating loss MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton
CorLife to become the exclusive distributor of the ReWalk Personal Exoskeleton for individuals with Workers' Compensation claims
Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton
Charts implemented using Lightweight Charts™